ResearcherSichuan UniversityActive in the last 2 years
Tongbo Zhu
Matched on ORCID iD 0000-0003-4539-9484; OpenAlex author ID A5089499879. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 9
2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 6
- PKCζ regulates autophagy in pancreatic ductal adenocarcinoma via BAG3: a novel therapeutic vulnerability. Last author DOI 10.1016/j.bcp.2025.117176↗
- The BCL2-associated athanogene-3-Interferon-induced transmembrane protein 2 axis enhances pancreatic ductal adenocarcinoma growth via the Mitogen-activated pr… Co-author DOI 10.1093/carcin/bgae053↗
- PKCι induces differential phosphorylation of STAT3 to modify STAT3-related signaling pathways in pancreatic cancer cells. Last author DOI 10.1007/s12079-023-00780-9↗
- PKCι regulates the expression of PDL1 through multiple pathways to modulate immune suppression of pancreatic cancer cells. Last author DOI 10.1016/j.cellsig.2021.110115↗
- Mu-KRAS attenuates Hippo signaling pathway through PKCι to sustain the growth of pancreatic cancer. Last author DOI 10.1002/jcp.28981↗
- [The Effects of PKCι on Anti-tumor Activity of Cytokine-induced Killer Cells Against Pancreatic Cancer Cells and the Possible Underlying Mechanisms]. Last author PMID 31880112↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sijia Weng · 3 shared papers, 2021–2025 · strength 0.62
- Paper PKCζ regulates autophagy in pancreatic ductal adenocarcinoma via BAG3: a novel therapeutic vulnerability. DOI 10.1016/j.bcp.2025.117176↗
- Paper PKCι induces differential phosphorylation of STAT3 to modify STAT3-related signaling pathways in pancreatic cancer cell… DOI 10.1007/s12079-023-00780-9↗
- Paper PKCι regulates the expression of PDL1 through multiple pathways to modulate immune suppression of pancreatic cancer cel… DOI 10.1016/j.cellsig.2021.110115↗
- Peipei Wang · 2 shared papers, 2020–2024 · strength 0.35
- Hongmei Zhang · 2 shared papers, 2020–2021 · strength 0.26
- Yu Zhang · 1 shared paper, 2024 · strength 0.24
- Xia Wang · 1 shared paper, 2024 · strength 0.24
- Junli Wang · 1 shared paper, 2023 · strength 0.18
- Changyan Chen · 1 shared paper, 2020 · strength 0.11
- Peipei Wang · 1 shared paper, 2019 · strength 0.11
- Hongmei Zhang · 1 shared paper, 2019 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.